ATOS logo

Atossa Therapeutics (ATOS)

Profile

Full Name

Atossa Therapeutics, Inc.

Ticker Symbol

ATOS

Exchange

NASDAQ

Country

United States

IPO

November 8, 2012

Indexes

Not included

Employees

15

Key Details

Price

$0.86(+2.38%)

Market cap

$111.09M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.20(+16.67% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 21, 25 Ascendiant Capital
Buy
Mar 26, 25 HC Wainwright & Co.
Buy
Mar 12, 25 HC Wainwright & Co.
Buy
Jan 30, 25 HC Wainwright & Co.
Buy
Dec 13, 24 HC Wainwright & Co.
Buy
Dec 12, 24 HC Wainwright & Co.
Buy
Dec 9, 24 Ascendiant Capital
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Nov 5, 24 HC Wainwright & Co.
Buy
Oct 31, 24 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Atossa Therapeutics?
  • Does Atossa Therapeutics pay dividends?
  • What sector is Atossa Therapeutics in?
  • What industry is Atossa Therapeutics in?
  • What country is Atossa Therapeutics based in?
  • When did Atossa Therapeutics go public?
  • Is Atossa Therapeutics in the S&P 500?
  • Is Atossa Therapeutics in the NASDAQ 100?
  • Is Atossa Therapeutics in the Dow Jones?
  • When was Atossa Therapeutics's last earnings report?
  • When does Atossa Therapeutics report earnings?
  • Should I buy Atossa Therapeutics stock now?

What is the ticker symbol for Atossa Therapeutics?

The ticker symbol for Atossa Therapeutics is NASDAQ:ATOS

Does Atossa Therapeutics pay dividends?

No, Atossa Therapeutics does not pay dividends

What sector is Atossa Therapeutics in?

Atossa Therapeutics is in the Healthcare sector

What industry is Atossa Therapeutics in?

Atossa Therapeutics is in the Biotechnology industry

What country is Atossa Therapeutics based in?

Atossa Therapeutics is headquartered in United States

When did Atossa Therapeutics go public?

Atossa Therapeutics's initial public offering (IPO) was on November 8, 2012

Is Atossa Therapeutics in the S&P 500?

No, Atossa Therapeutics is not included in the S&P 500 index

Is Atossa Therapeutics in the NASDAQ 100?

No, Atossa Therapeutics is not included in the NASDAQ 100 index

Is Atossa Therapeutics in the Dow Jones?

No, Atossa Therapeutics is not included in the Dow Jones index

When was Atossa Therapeutics's last earnings report?

Atossa Therapeutics's most recent earnings report was on Mar 25, 2025

When does Atossa Therapeutics report earnings?

The next expected earnings date for Atossa Therapeutics is May 13, 2025

Should I buy Atossa Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page